Published February 2006 | Version v1
Journal article

Chemoselective hydrazone formation between HYNIC-functionalized peptides and 18F-fluorinated aldehydes

  • 1. Department of Nuclear Medicine, Klinikum rechts der Isar, Technischen Universitaet Muenchen, D-81675 Munich (Germany)

Description

Introduction: Since the demand for 18F-fluorinated peptides for quantitative in vivo receptor imaging using PET has increased, a new chemoselective two-step 18F-labeling strategy based on hydrazone formation between an unprotected hydrazine-functionalized peptide and an 18F-labeled aldehyde was developed. Methods: First, 4-[18F]fluorobenzaldehyde ([18F]FB-CHO) was prepared from 4-formyl-N,N,N-trimethylanilinium triflate via direct no-carrier-added 18F-fluorination (dimethyl sulfoxide, 90oC, 5 min) and purified by RP-HPLC. Hydrazone formation between [18F]FB-CHO and 6-hydrazinonicotinic acid (HYNIC) and the unprotected HYNIC-functionalized peptides (HYNIC-D-Phe1)-Tyr3-Thr8-octreotide and (HYNIC-Arg1)-substance P was evaluated with respect to the dependence of radiochemical yield on pH, precursor concentration and temperature. The stability of [18F]FB-CH=N-HYNIC-Tyr3-Thr8(NH2)-octreotide in aqueous solution at various pH (4.0, 5.5 and 7.5) as well as the in vivo stability of [18F]FB-CH=N-HYNIC-Tyr3-Thr8-octreotide in mouse blood (30 min p.i.) was investigated. Results: Yields of the hydrazone formation were independent of pH between pH 0.5 and 5.5. Optimal labeling yields of 85% were obtained with a precursor concentration of 2.1 mM at 70oC for 10 min. The labeling products were stable at pH 7.5 at 37oC, while in more acidic media (pH 4.0) the product slowly decomposed to form up to 31±2% [18F]FB-CHO within 5 h. Metabolite studies showed no detectable degradation of [18F]FB-CH=N-HYNIC-Tyr3-Thr8-octreotide in mouse blood (30 min p.i.). Conclusions: In conclusion, chemoselective hydrazone formation between unprotected HYNIC-functionalized peptides and [18F]FB-CHO is a fast and straightforward radiolabeling method leading to high yields under mild acidic conditions. In addition, it represents a powerful and versatile radiolabeling strategy that is applicable to a variety of radionuclides and peptide precursors already available for 99mTc labeling

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2005.10.010;
PII
S0969-8051(05)00274-X;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
33
Journal Issue
2
Journal Page Range
p. 173-183
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.